Sachet A Shukla Selected Research

Immune Checkpoint Inhibitors

3/2024	Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
1/2022	Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
1/2022	HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.
1/2021	Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma.
1/2021	Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
1/2021	CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.
1/2020	Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
11/2019	Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma.
1/2019	Metabolomic adaptations and correlates of survival to immune checkpoint blockade.
1/2018	Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sachet A Shukla Research Topics

Disease

35	Neoplasms (Cancer) 03/2024 - 07/2012
11	Melanoma (Melanoma, Malignant) 01/2022 - 10/2015
8	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2019
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2012
3	Carcinoma (Carcinomatosis) 01/2021 - 03/2016
2	Triple Negative Breast Neoplasms 12/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2014
2	Tics (Tic) 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2016
2	Endometrial Neoplasms (Endometrial Cancer) 02/2017 - 12/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Residual Neoplasm 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Testicular Neoplasms (Testicular Cancer) 01/2016
1	Glioma (Gliomas) 12/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2014
1	Leukemia 07/2014
1	Cardiomyopathies (Cardiomyopathy) 02/2011

Drug/Important Bio-Agent (IBA)

15	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2015
7	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
5	NivolumabIBA 01/2022 - 01/2019
5	VaccinesIBA 01/2021 - 01/2017
4	EpitopesIBA 01/2022 - 01/2019
4	Peptides (Polypeptides)IBA 01/2022 - 07/2014
4	AntigensIBA 01/2022 - 01/2016
4	MicroRNAs (MicroRNA)IBA 10/2017 - 07/2012
3	Everolimus FDA Link 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 10/2017 - 08/2012
1	atezolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Estrogen ReceptorsIBA 01/2021
1	PlatinumIBA 01/2021
1	Protein Subunit VaccinesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Sucrose (Saccharose)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2018
1	LigandsIBA 01/2018
1	Ligases (Synthetase)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Histocompatibility Antigens Class IIBA 10/2017
1	Long Noncoding RNAIBA 10/2017
1	Calcibiotic Root Canal SealerIBA 04/2016
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2016
1	Amino Acids FDA Link 01/2016
1	IpilimumabIBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015
1	AntagomirsIBA 12/2014
1	Transcription Factors (Transcription Factor)IBA 11/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011

Therapy/Procedure

9	Therapeutics 03/2024 - 10/2015
9	Immunotherapy 03/2024 - 12/2015
2	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Radiotherapy 01/2019 - 12/2014
1	Drug Therapy (Chemotherapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2020